Correlation Between Genelux Common and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genelux Common and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genelux Common and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Genelux Common and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Corbus Pharmaceuticals.
Diversification Opportunities for Genelux Common and Corbus Pharmaceuticals
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Genelux and Corbus is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Genelux Common i.e., Genelux Common and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genelux Common and Corbus Pharmaceuticals
Given the investment horizon of 90 days Genelux Common is expected to generate 5.67 times less return on investment than Corbus Pharmaceuticals. But when comparing it to its historical volatility, Genelux Common is 1.81 times less risky than Corbus Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Corbus Pharmaceuticals Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 990.00 in Corbus Pharmaceuticals Holding on February 7, 2024 and sell it today you would earn a total of 2,887 from holding Corbus Pharmaceuticals Holding or generate 291.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 65.05% |
Values | Daily Returns |
Genelux Common vs. Corbus Pharmaceuticals Holding
Performance |
Timeline |
Genelux Common |
Corbus Pharmaceuticals |
Genelux Common and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genelux Common and Corbus Pharmaceuticals
The main advantage of trading using opposite Genelux Common and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.Genelux Common vs. Veritas Pharma | Genelux Common vs. Sangui Biotech International | Genelux Common vs. Raphael Pharmaceutical | Genelux Common vs. GelStat Corp |
Corbus Pharmaceuticals vs. Veritas Pharma | Corbus Pharmaceuticals vs. Sangui Biotech International | Corbus Pharmaceuticals vs. Raphael Pharmaceutical | Corbus Pharmaceuticals vs. GelStat Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |